Page 7 - Philipp Mathieu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Philipp Mathieu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Philipp Mathieu Today - Breaking & Trending Today

Immunovia strengthens US organization to continue commercialization of its novel IMMray™ PanCan-d test

Published: December 5, 2022

/PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world's first blood test dedicated to the early detection...

Source: prnewswire.co.uk

Centers for Medicare & Medicaid Services finalizes its payment determination and sets a rate of $897 for Immunovia's IMMray PanCan-d test

Published: November 30, 2022

/PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV) today announced that the Centers for Medicare and Medicaid Services (CMS) has finalized their payment...

Source: prnewswire.com

Immunovia AB: Centers for Medicare & Medicaid Services finalizes its payment determination and sets a rate of $897 for Immunovia's IMMray PanCan-d test

Published: November 30, 2022

LUND, Sweden, Nov. 30, 2022 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV) today announced that the Centers for Medicare and Medicaid Services (CMS) has finalized their payment determination

Source: finanznachrichten.de

Related Topics:

Immunovia AB: Chief Executive Offier, Philipp Mathieu, buys Immunovia warrants

Published: November 16, 2022

LUND, Sweden, Nov. 16, 2022 /PRNewswire/ -- Immunovia AB (NASDAQ: IMMNOV) announces today that Philipp Mathieu, CEO of Immunovia, has purchased 150000 warrants of the 2022/2026 scheme for approximately